Skip to main content

ADA4003 Real-World Evidence of Duration of Effect of Adhansia XR for Treatment of ADHD (RE-DAX)

NCT04507204

Real-World Evidence of Duration of Effect of Adhansia XR for Treatment of ADHD (RE-DAX)

Associated Conditions

ADHD

Principal Investigator

Sponsor

Adlon Therapeutics

The main purpose of this study is to test if Adhansia XR is effective in treating adolescent and adult patients diagnosed with ADHD. In addition, Adhansia XR's effectiveness in treating ADHD will be compared with OROS MPH (or its generic versions). Other purposes of the study are to describe the safety of the study drugs and the participant's quality of life and burden of illness.

This study is currently enrolling.